EUVIMEDEUVIMED entdecken
Open Access

Cardiac Sympathetic Denervation Mitigated Ischemic Cardiomyopathy Progression in a Rat Model of Sleep Apnea

Maximin Détrait iD, Jonathan Gaucher iD, Emma Billoir iD, Sophie Bouyon iD, Emeline Lemarié iD, Stéphanie Paradis iD, Guillaume Vial iD, Florent Chuffart, Côme Pasqualin iD, Fabien Hubert iD, Francesca Rochais iD, Stéphane Doutreleau iD und 4 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Maximin Détrait und 15 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2 Grenoble France. Hauptthemen laut MEDLINE: Sympathectomy, Cardiomyopathies, Sleep Apnea, Obstructive, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischemic cardiomyopathy with comorbid obstructive sleep apnea syndrome is associated with worse long‐term outcomes. Intermittent hypoxia (IH), a key feature of obstructive sleep apnea, exacerbates sympathetic activity, hastening cardiac dysfunction and remodeling in ischemic cardiomyopathy rat models. This study explores whether targeted cardiac sympathetic denervation (CSD) can limit IH‐induced progression of ischemic cardiomyopathy.

Methods

Male Wistar rats underwent CSD, through ablation of the left middle cervical and stellate ganglions, and simultaneously myocardial infarction, via permanent left coronary artery ligation. Three days post surgery, rats were exposed to IH (21%–5% fraction of inspired O 2 , 60‐second cycle, 8 hours/day) or normoxia. At 6 weeks, calcium transient, sarcomere shortening, and adrenergic reserve in response to isoproterenol (100 nmol/L) were assessed in isolated cardiomyocytes. At 14 weeks, sympathovagal balance, cardiac function, and remodeling were evaluated.

Results

Post myocardial infarction, CSD prevented IH‐induced blunting of cardiomyocyte response to isoproterenol challenge and reduced cardiac sympathetic activity. In hypoxic animals, CSD reduced post‐myocardial infarction alterations in long‐term ejection fraction and mitigated cardiomyocyte hypertrophy and apoptosis. Transcriptomic analysis unveiled that CSD triggered biological processes related to cardiac repair and regeneration. Immunohistochemistry further supported these findings, demonstrating increased cardiomyocyte proliferation in the hypoxic group, as indicated by elevated Ki67 expression colocalized with MF20 markers.

Conclusions

Our data demonstrate that CSD prevents IH‐induced sympathetic hyperactivity, depletion of cardiac adrenergic reserve, and deterioration of cardiac function in a rat model of ischemic cardiomyopathy. This study highlights the intricate interplay between sympathetic activity and hypoxia in cardiac regeneration and underscores the importance of managing sympathetic hyperactivity in ischemic cardiomyopathy, particularly in the context of comorbid obstructive sleep apnea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SympathectomyCardiomyopathiesSleep Apnea, ObstructiveMyocardial InfarctionSleep Apnea SyndromesMyocardial IschemiaAnimalsMaleRats, WistarDisease Models, AnimalDisease ProgressionVentricular RemodelingMyocytes, CardiacRatsHypoxiaVentricular Function, LeftSympathetic Nervous System

Stichwörter der Autor:innen

cardiac sympathetic denervationintermittent hypoxiaischemic cardiomyopathysleep apneasympathetic activity

Autor:innen und Institutionen

  • Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2 Grenoble France.
  • Université Grenoble Alpes, INSERM U1209, CNRS UMR5309, IAB Grenoble France.
  • Niche, Nutrition, Cancer & Oxidative metabolism (N2COx), UMR 1069, INSERM, University of Tours Tours France.
  • Aix-Marseille Université, INSERM, MMG, U1251 Marseille France.

ORCID-Profile: Maximin Détrait, Jonathan Gaucher, Emma Billoir, Sophie Bouyon, Emeline Lemarié, Stéphanie Paradis, Guillaume Vial, Côme Pasqualin, Fabien Hubert, Francesca Rochais, Stéphane Doutreleau, Jean-Louis Pépin, Diane Godin-Ribuot, Elise Belaidi, Claire Arnaud

Zitieren

APA

Détrait, M., Gaucher, J., Billoir, E., Bouyon, S., Lemarié, E., Paradis, S., Vial, G., Chuffart, F., Pasqualin, C., Hubert, F., Rochais, F., Doutreleau, S., Pépin, J. L., Godin-Ribuot, D., Belaidi, E., & Arnaud, C. (2025). Cardiac Sympathetic Denervation Mitigated Ischemic Cardiomyopathy Progression in a Rat Model of Sleep Apnea. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038781

Vancouver

Détrait M, Gaucher J, Billoir E, Bouyon S, Lemarié E, Paradis S, et al. Cardiac Sympathetic Denervation Mitigated Ischemic Cardiomyopathy Progression in a Rat Model of Sleep Apnea. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038781

BibTeX
@article{Dtrait2025,
  author = {Détrait, Maximin and Gaucher, Jonathan and Billoir, Emma and Bouyon, Sophie and Lemarié, Emeline and Paradis, Stéphanie and Vial, Guillaume and Chuffart, Florent and Pasqualin, Côme and Hubert, Fabien and Rochais, Francesca and Doutreleau, Stéphane and Pépin, Jean-Louis and Godin-Ribuot, Diane and Belaidi, Elise and Arnaud, Claire},
  title = {Cardiac Sympathetic Denervation Mitigated Ischemic Cardiomyopathy Progression in a Rat Model of Sleep Apnea},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038781}
}
Kostenlos starten →